Use of low-molecular-weight heparin as bridge anticoagulation therapy in patients with atrial fibrillation undergoing transoesophageal echocardiography guided cardioversion.
Murray
R D
RD
Deitcher
S R
SR
Klein
A L
AL
D000925:Anticoagulants / Q000627:therapeutic use*; D001281:Atrial Fibrillation / Q000000981:diagnostic imaging / Q000628:therapy*; D017548:Echocardiography, Transesophageal; D004554:Electric Countershock; D005240:Feasibility Studies; D006495:Heparin, Low-Molecular-Weight / Q000627:therapeutic use*; D006801:Humans; D018579:Patient Selection; D012307:Risk Factors; D012449:Safety; D018084:Ultrasonography, Interventional
D000925:Anticoagulants; D006495:Heparin, Low-Molecular-Weight